Drug news
Nordic rights to ReFacto and BeneFIX are returned to Pfizer
Pfizer has taken back the Nordic territory rights to reclaim to the blood clotting factors ReFacto and BeneFIX from Swedish Orphan Biovitrum which held co-promotion rights there.The drugs will continue to be manufactured in Sweden.